Ausgabe 11/2005
Inhalt (10 Artikel)
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation
Johannes Schetelig, Alexander Kiani, Marc Schmitz, Gerhard Ehninger, Martin Bornhäuser
CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation
An Willems, Steve Schoonooghe, Dominique Eeckhout, Geert De Jaeger, Johan Grooten, Nico Mertens
Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites
Andreas E. Albers, Robert L. Ferris, Grace G. Kim, Kazuaki Chikamatsu, Albert B. DeLeo, Theresa L. Whiteside
Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine
Deborah J. Marshall, Lani R. San Mateo, Kelly A. Rudnick, Stephen G. McCarthy, Michael C. Harris, Christine McCauley, Allen Schantz, Dong Geng, Pam Cawood, Linda A. Snyder
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients
William Chad Cragun, Galina V. Yamshchikov, Eric A. Bissonette, Mark E. Smolkin, Shannon Eastham, Gina R. Petroni, Randy S. Schrecengost, Elizabeth M. H. Woodson, Craig L. Slingluff Jr
Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain
Guo Xiaoling, Liu Ying, Liu Jing, Li Huifang, Zhu Xia, Fan Qingqing, Zhu Ping
Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages
Hui Li, Ming Y. Cao, Yoon Lee, Vivian Lee, Ningping Feng, Tania Benatar, Hongnan Jin, Ming Wang, Sandy Der, Jim A. Wright, Aiping H. Young
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
Pratima Sinha, Virginia K. Clements, Seth Miller, Suzanne Ostrand-Rosenberg
The interplay between innate and adaptive immunity regulates cancer development
K. E. de Visser, L. M. Coussens